Patiromer for the Management of Hyperkalemia in Heart Failure Patients with Reduced Ejection Fraction Receiving Renin-Angiotensin-Aldosterone System Inhibitors: Results from a Prespecified Chronic Kidney Disease Subgroup Analysis: the Diamond Trial: